Roth Gregory A, Forouzanfar Mohammad H, Moran Andrew E, Barber Ryan, Nguyen Grant, Feigin Valery L, Naghavi Mohsen, Mensah George A, Murray Christopher J L
From the Department of Medicine, Division of Cardiology (G.A.R.), and the Institute for Health Metrics and Evaluation (G.A.R., M.H.F., R.B., G.N., M.N., C.J.L.M.), University of Washington, Seattle; Department of Medicine, Division of General Medicine, Columbia University, New York (A.E.M.); National Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand (V.L.F.); and the Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (G.A.M.).
N Engl J Med. 2015 Apr 2;372(14):1333-41. doi: 10.1056/NEJMoa1406656.
Global deaths from cardiovascular disease are increasing as a result of population growth, the aging of populations, and epidemiologic changes in disease. Disentangling the effects of these three drivers on trends in mortality is important for planning the future of the health care system and benchmarking progress toward the reduction of cardiovascular disease.
We used mortality data from the Global Burden of Disease Study 2013, which includes data on 188 countries grouped into 21 world regions. We developed three counterfactual scenarios to represent the principal drivers of change in cardiovascular deaths (population growth alone, population growth and aging, and epidemiologic changes in disease) from 1990 to 2013. Secular trends and correlations with changes in national income were examined.
Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth. The relative contributions of these drivers varied by region; only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline. Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere.
The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions. Only Central and Western Europe had gains in cardiovascular health that were sufficient to offset these demographic forces. (Funded by the Bill and Melinda Gates Foundation and others.).
由于人口增长、人口老龄化以及疾病的流行病学变化,全球心血管疾病死亡人数正在增加。厘清这三个驱动因素对死亡率趋势的影响,对于规划医疗保健系统的未来以及衡量在降低心血管疾病方面取得的进展至关重要。
我们使用了《2013年全球疾病负担研究》中的死亡率数据,该数据涵盖了188个国家,分为21个世界区域。我们制定了三种反事实情景,以代表1990年至2013年心血管疾病死亡变化的主要驱动因素(仅人口增长、人口增长和老龄化以及疾病的流行病学变化)。研究了长期趋势以及与国民收入变化的相关性。
尽管特定年龄死亡率下降了39%,但1990年至2013年期间全球心血管疾病死亡人数仍增加了41%;这一增长是由人口老龄化导致的死亡率上升55%以及人口增长导致的死亡率上升25%推动的。这些驱动因素的相对贡献因地区而异;只有中欧和西欧的心血管疾病年度死亡人数实际下降。人均国内生产总值的变化仅在中高收入国家与特定年龄死亡率的变化相关,且这种相关性较弱;其他地区则无显著相关性。
尽管大多数地区的特定年龄死亡率有所下降,但1990年至2013年期间,人口老龄化和增长导致全球心血管疾病死亡人数增加。只有中欧和西欧在心血管健康方面取得了足以抵消这些人口因素的进展。(由比尔及梅琳达·盖茨基金会等资助。)